Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 1/20 | 0.56 |
| ▸ | FNTB | P49356 | 1/20 | 0.56 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.56 |
| ▸ | LTA4H | P09960 | 1/20 | 0.55 |
| ▸ | NPY1R | P25929 | 1/20 | 0.54 |
| ▸ | NPY2R | P49146 | 1/20 | 0.54 |
| ▸ | NPY4R | P50391 | 1/20 | 0.54 |
| ▸ | MME | P08473 | 1/20 | 0.54 |
| ▸ | BACE1 | P56817 | 2/20 | 0.53 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3646826 | 1.00 | FNTA (0.56) | FNTAFNTBPGGT1BLTA4HNPY1R | |
| SCHEMBL907360 | 1.00 | FNTA (0.56) | FNTAFNTBPGGT1BLTA4HNPY1R | |
| Acetic Acid SCHEMBL15201182 | 0.98 | LTA4H (0.56) | FNTAFNTBPGGT1BLTA4HNPY1R | |
| Acetic Acid SCHEMBL15201179 | 0.98 | LTA4H (0.56) | FNTAFNTBPGGT1BLTA4HNPY1R | |
| Formic Acid SCHEMBL27865482 | 0.96 | FNTA (0.52) | FNTAFNTBPGGT1BLTA4HNPY1R | |
| SCHEMBL16430978 | 0.96 | LTA4H (0.58) | FNTAFNTBPGGT1BLTA4HMME | |
| SCHEMBL16430977 | 0.96 | LTA4H (0.58) | FNTAFNTBPGGT1BLTA4HMME | |
| SCHEMBL30917374 | 0.94 | FNTA (0.56) | FNTAFNTBPGGT1BLTA4HBACE1 | |
| SCHEMBL16556113 | 0.92 | NPY4R (0.56) | FNTAFNTBPGGT1BNPY1RNPY2R | |
| SCHEMBL16556111 | 0.92 | NPY4R (0.56) | FNTAFNTBPGGT1BNPY1RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1204 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3497445-A2 | MICROPATTERNING ASSEMBLY, METHODS FOR MICROPATTERNING, AND MICROPATTERNED DEVICES | Institute of Science and Technology Austria (AT) | 2019-06-19 | — | — | EP | claimed |
| WO-2018029315-A2 | MICROPATTERNING ASSEMBLY, METHODS FOR MICROPATTERNING, AND MICROPATTERNED DEVICES | IST AUSTRIA - INSTITUTE OF SCIENCE AND TECHNOLOGY AUSTRIA (AT) | 2018-02-15 | — | — | WO | claimed |
| EP-1800692-B1 | Immunological compositions and vaccines containing N-formyl methionyl peptide as adjuvant | CONNAUGHT TECHNOLOGY CORP (US) | 2011-01-26 | — | — | EP | claimed |
| EP-1599226-A4 | A METHOD OF DIAGNOSIS AND TREATMENT | MEDVET SCIENCE PTY LTD (AU) | 2007-11-21 | — | — | EP | claimed |
| EP-1800692-A1 | Novel adjuvant for subunit or component vaccines | Connaught Technology Corporation (US) | 2007-06-27 | — | — | EP | claimed |
| EP-1599226-A1 | A METHOD OF DIAGNOSIS AND TREATMENT | MEDVET SCIENCE PTY. LTD. (AU) | 2005-11-30 | — | — | EP | claimed |
| WO-2004073739-A1 | A METHOD OF DIAGNOSIS AND TREATMENT | MEDVET SCIENCE PTY. LTD. (AU) | 2004-09-02 | — | — | WO | claimed |
| CN-114080232-B | Extracellular vesicles for vaccine delivery | Lhasa Sales Co.,Ltd. (CH) | 2026-05-26 | — | — | CN | disclosed |
| CN-115335392-B | Inhibition of shade-avoidance response in plants | 成对植物服务股份有限公司 | 2026-05-15 | — | — | CN | disclosed |
| EP-4658323-A1 | RECOMBINANT ADENO-ASSOCIATED VIRUS VECTOR | Quethera Limited (GB) | 2025-12-10 | — | — | EP | disclosed |
| CN-113444183-B | Fusion partners for peptide production | 佩利肯科技控股公司 | 2025-06-17 | — | — | CN | disclosed |
| CN-111787951-B | IgM Fc and J chain mutations affecting IgM serum half-life | IGM生物科学股份有限公司 | 2025-06-17 | — | — | CN | disclosed |
| CN-112261874-B | Inhibition of fungal growth by manganese depletion | 科·汉森有限公司 | 2025-06-17 | — | — | CN | disclosed |
| WO-1992001464-A1 | INHIBITION OF MAC-1 RECEPTOR BINDING TO FIBRINOGEN USING D30 HOMOLOGS | THE SCRIPPS RESEARCH INSTITUTE (US) | 1992-02-06 | — | — | WO | disclosed |
| US-5043424-A | Modification method for peptides and proteins by reacting with a phosphoric acid ester | KAO CORPORATION (JP) | 1991-08-27 | — | — | US | disclosed |
| EP-0438497-A1 | VASOPERMEABILITY-ENHANCING CONJUGATES. | UNIV SOUTHERN CALIFORNIA (US) | 1991-07-31 | — | — | EP | disclosed |
| EP-0398143-A1 | Labeled chemotactic peptides to image focal sites of infection or inflammation | THE GENERAL HOSPITAL CORPORATION (US) | 1990-11-22 | — | — | EP | disclosed |
| WO-1990013317-A1 | LABELED CHEMOTATIC PEPTIDES TO IMAGE FOCAL SITES OF INFECTION OR INFLAMMATION | THE GENERAL HOSPITAL CORPORATION (US) | 1990-11-15 | — | — | WO | disclosed |
| WO-1990003801-A1 | VASOPERMEABILITY-ENHANCING CONJUGATES | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 1990-04-19 | — | — | WO | disclosed |
| EP-0312963-A2 | Modification method for peptides and proteins | Kao Corporation (JP) | 1989-04-26 | — | — | EP | disclosed |